Scientists zoom in: mapping how a psoriasis drug heals skin
NCT ID NCT07244744
Summary
This study aims to understand how a specific psoriasis drug, tildrakizumab, works in the skin. Researchers will analyze tiny skin samples from three adults with moderate-to-severe psoriasis before and after treatment. The goal is to see how the drug changes skin cells over time to learn more about its healing effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CCIM, Institut für Entzündungsmedizin UKSH Lübeck
Lübeck, <Keine Auswahl>, 23562, Germany
Conditions
Explore the condition pages connected to this study.